Method of reducing exercise-induced joint pain in non-arthritic mammals
View Patent ↗The present invention relates to a method of treating exercise-induced joint pain in arthritis-free mammals by the administration of undenatured Type II collagen.
1. A method of treating exercise-induced joint pain in an arthritis-free mammal comprising administering undenatured Type II collagen in an amount effective to reduce such exercise-induced joint pain, wherein the reduction in joint pain is evidenced by improvements in range motion.
2. A method of lengthening the period of joint pain free strenuous exercise in an arthritis-free mammal comprising administering undenatured Type II collagen in an amount effective to lengthen the period of strenuous exercise before joint pain is experienced, wherein the reduction in joint pain is evidenced by improvements in range motion.
3. A method of speeding recovery from exercise-induced joint pain in arthritis-free mammals comprising administering undenatured Type II collagen in an amount effective to speed the recovery from exercise-induced joint pain, wherein the reduction in joint pain is evidenced by improvements in range motion.
4. A method of treating joint pain in an arthritis-free mammal which is due to a mechanical stressor comprising administering undenatured Type II collagen in an amount effective to reduce such joint pain, wherein the reduction in joint pain is evidenced by improvements in range motion.
5. The method of claim 4 wherein the mechanical stressor is acute injury.
6. The method of claim 4 wherein the mechanical stressor is strenuous exercise.
7. A method of reducing joint pain during strenuous exercise in arthritis-free mammals comprising administering undenatured Type II collagen in an amount effective to reduce such exercise-induced joint pain wherein the joint pain is knee pain and wherein the reduction in knee joint pain is evidenced by improvements in range of motion.
8. A method of reducing joint pain during strenuous exercise in arthritis-free mammals comprising administering undenatured Type II collagen in an amount effective to reduce such exercise-induced joint pain wherein the joint pain is knee pain and wherein the reduction in knee joint pain is evidenced by improvements in knee joint extension.
9. The method of claim 7 or 8 wherein the mammal is a human.
10. The method of claim 7 or 8 wherein the undenatured Type II collagen is administered in a dosage of from 0.1 mg to 5000 mg per day.
11. The method of claim 7 or 8 wherein the undenatured Type II collagen is administered in a dosage of from 1 mg to 200 mg per day.
12. The method of claim 7 or 8 wherein the undenatured Type II collagen is administered in a dosage of from 5 mg to 40 mg per day.
13. The method of claim 7 or 8 wherein the undenatured Type II collagen is consumed orally.
14. The method of claim 7 or 8 wherein the undenatured Type II collagen is consumed in the form of a dosage form selected from the group consisting of capsules, tablets, gummy chewable, lozenge, powder.
15. The method of claim 7 or 8 wherein the undenatured Type II collagen is consumed in a syrup or liquid suspension.
16. The method of claim 7 or 8 wherein the undenatured Type II collagen is consumed in the form of an edible supplement.